hotspot -WSS

hotspot

author：knowledge 2025-09-07 06:40:34 - browse：769

Each COVID-19 vaccine vial from various companies is placed on individual rectangular backgrounds. Pfizer-BioNTech is positioned in the middle on a purple block adorned with two glitter star stickers, Moderna is on the top right on a red block, Janssen is on the bottom right on a blue block, and AstraZeneca is on the left on a red block. — Illustration: Christine Kao/STAT; Photos: Getty

It’s been four years since Covid-19 emerged, igniting a pandemic that killed millions of people and brought the world to its knees. A key factor in taming the pandemic was the creation of effective vaccines, which have saved millions of lives.

You’d think developing a successful vaccine would be an unmitigated win, from a financial perspective. And, indeed, for Pfizer and its partner BioNTech, as well as for Moderna — whose vaccines were the most widely used in the United States and much of the world — the revenues generated were absolutely staggering. But investors have shrugged at those sales as gains that will not be repeated.

Total sales of the Pfizer/BioNTech vaccine surpassed $80 billion, and more than 400 million doses of the shot and subsequent boosters have been administered in the U.S. alone. But the company’s stock price fell 32% over the past five years. Meanwhile, AstraZeneca, which told STAT it has not booked sales from its vaccine since last April and does not expect future sales, has seen its share price rise 64%. Merck, which saw its vaccine efforts fail twice, is up 56%.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： PhRMA sues HHS over Medicare drug price negotiation

WSS

How clinical AI models' predictive power can degrade over time

Make 'food is medicine' a key part of White House nutrition meeting

Why is France rioting? What to know about the fatal police shooting of Nahel M

What the Wegovy shortage looks like for doctors — and for patients

Cancer cells are shown to suck energy source from immune cells

Bacterial infection may be ‘key event’ in endometriosis, study says

Wikipedia

hotspot

hotspot

After affirmative action ruling, medical educators look to 'holistic review'

Did the public have the right to know Arthur Ashe had AIDS?

After affirmative action ruling, medical educators look to 'holistic review'

Better Therapeutics data on benefit with GLP

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Listen: Biogen's messy board & Laronde's data problem

23andMe had bad news about my health. I wish a person had delivered it

Humana CEO Bruce Broussard to step down in 2024

Supreme Court strikes down use of affirmative action

Bernie Sanders bashes nonprofit hospitals over their tax breaks

leisure time

A fraught question for the kids of Alzheimer’s: Is it coming for us?

How clinical AI models' predictive power can degrade over time

Bernie Sanders bashes nonprofit hospitals over their tax breaks

How doctors and nurses shape Google's AI

UnitedHealth’s Q3 profit jumps as medical costs rise more slowly

Connecting traumatic brain injury and domestic violence

explore

entertainment

knowledge

focus